...
首页> 外文期刊>BMC Pediatrics >Diagnostic difficulties and possibilities of NF1-like syndromes in childhood
【24h】

Diagnostic difficulties and possibilities of NF1-like syndromes in childhood

机译:童年时代NF1样综合征的诊断困难及可能性

获取原文
           

摘要

Neurofibromatosis type 1 (NF1), which is caused by heterozygous inactivating pathogenic variants in the NF1, has poor phenotypic expressivity in the early years of life and there are numerous conditions, including many other tumor predisposition syndromes, that can mimic its appearance. These are collectively termed NF1-like syndromes and are also connected by their genetic background. Therefore, the NF1’s clinical diagnostic efficiency in childhood could be difficult and commonly should be completed with genetic testing. To estimate the number of syndromes/conditions that could mimic NF1, we compiled them through an extensive search of the scientific literature. To test the utility of NF1’s National Institutes of Health (NIH) clinical diagnostic criteria, which have been in use for a long time, we analyzed the data of a 40-member pediatric cohort with symptoms of the NF1-like syndromes’ overlapping phenotype and performed NF1 genetic test, and established the average age when diagnostic suspicion arises. To facilitate timely identification, we compiled strongly suggestive phenotypic features and anamnestic data. In our cohort the utility of NF1’s clinical diagnostic criteria were very limited (sensitivity: 80%, specificity: 30%). Only 53% of children with clinically diagnosed NF1 had a detectable NF1 pathogenic variation, whereas 40% of patients without fulfilled clinical criteria tested positive. The average age at first genetic counseling was 9 years, and 40% of children were referred after at least one tumor had already been diagnosed. These results highlight the need to improve NF1-like syndromes’ diagnostic efficiency in childhood. We collected the most extensive spectrum of NF1-like syndromes to help the physicians in differential diagnosis. We recommend the detailed, non-invasive clinical evaluation of patients before referring them to a clinical geneticist. Early diagnosis of NF1-like syndromes can help to prevent severe complications by appropriate monitoring and management. We propose a potential screening, diagnostic and management strategy based on our findings and recent scientific knowledge.
机译:神经纤维瘤病类型1(NF1)是由NF1中的杂合子灭活致病变异引起的,在生命的早期表型表达差异差,包括许多其他肿瘤倾向综合征,包括模仿其外观。这些统称为NF1样综合征,也通过其遗传背景连接。因此,NF1在儿童时期的临床诊断效率可能是困难的,并且通常应通过遗传测试完成。为了估算可能模拟NF1的综合征/条件的数量,我们通过广泛地搜索科学文献来编制它们。要测试NF1国家健康研究院(NIH)临床诊断标准的效用,已经使用了很长时间,我们分析了40个成员儿科队列的数据,其症状与NF1样综合征重叠表型的症状进行NF1遗传测试,并在诊断怀疑时建立了平均年龄。为了促进及时鉴定,我们编制了强烈暗示的表型特征和Anamnestic数据。在我们的队列中,NF1的临床诊断标准的效用非常有限(敏感:80%,特异性:30%)。只有53%的临床诊断的NF1儿童具有可检测的NF1致病变异,而40%的患者没有满足的临床标准测试阳性。第一次遗传咨询的平均年龄为9岁,在至少一个肿瘤被诊断后,40%的儿童被提及。这些结果突出了提高童年时代的NF1样综合征的诊断效率的需要。我们收集了最广泛的NF1样综合征,以帮助医生在鉴别诊断中。我们向临床遗传学家提出了对患者的详细的,非侵入性的临床评估。早期诊断NF1样综合征可以通过适当的监测和管理来帮助防止严重的并发症。我们提出了基于我们的研究结果和最近的科学知识的潜在筛选,诊断和管理战略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号